62 related articles for article (PubMed ID: 6260511)
1. Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera.
McConnell I; Gorman NT; Raniwalla J; Powell P
Eur J Immunol; 1981 Feb; 11(2):126-32. PubMed ID: 6260511
[TBL] [Abstract][Full Text] [Related]
2. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
McConnell I; Klein G; Lint TF; Lachmann PJ
Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
[TBL] [Abstract][Full Text] [Related]
4. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
Praz F; Lesavre P
J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
[TBL] [Abstract][Full Text] [Related]
5. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
6. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
7. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
Hirsch RL; Griffin DE; Winkelstein JA
J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
9. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
10. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
Joseph BS; Cooper NR; Oldstone MB
J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789
[TBL] [Abstract][Full Text] [Related]
11. Heterotoxicity of human serum. IV. Role of the alternative complement pathway and natural antibody in the lethal toxicity of human serum for mice.
Rozenfarb E; Eidinger D
Int Arch Allergy Appl Immunol; 1979; 60(4):414-26. PubMed ID: 500231
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
Kuwajima S
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
[TBL] [Abstract][Full Text] [Related]
13. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.
Lévi-Strauss M; Mallat M
J Immunol; 1987 Oct; 139(7):2361-6. PubMed ID: 3655365
[TBL] [Abstract][Full Text] [Related]
14. Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum.
McConnell I; Klein G; Macanovic M; Gorman NT; Raniwalla J
Eur J Immunol; 1981 Feb; 11(2):132-5. PubMed ID: 6938374
[TBL] [Abstract][Full Text] [Related]
15. The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes.
Eisenberg RA; Theofilopoulos AN; Dixon FJ
J Immunol; 1979 May; 122(5):2045-51. PubMed ID: 87451
[TBL] [Abstract][Full Text] [Related]
16. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
Mosser DM; Edelson PJ
J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
[TBL] [Abstract][Full Text] [Related]
17. High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation.
Ghannam A; Hammache D; Matias C; Louwagie M; Garin J; Gerlier D
Mol Immunol; 2008 Jun; 45(11):3036-44. PubMed ID: 18455798
[TBL] [Abstract][Full Text] [Related]
18. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
Hunder GG; McDuffie FC; Clark RJ
J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
[TBL] [Abstract][Full Text] [Related]
19. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
Lambré C; Thibon M
Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
[TBL] [Abstract][Full Text] [Related]
20. Antibody-independent activation of the classical pathway of complement by Epstein-Barr virus.
Martin H; McConnell I; Gorick B; Hughes-Jones NC
Clin Exp Immunol; 1987 Mar; 67(3):531-6. PubMed ID: 3038440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
